Recent Updates
Recently added Catalysts
RDY Positive Sentiment Score: 65/100

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN : L85195TG1984PLC004507 Tel : +91 40 4900 2900 Fax : +91 40 4900 2999 Email : mail@drreddys.com www.drreddys.co

Key Takeaway: Dr. Reddy's Laboratories announced the allotment of 3,362 equity shares to employees under its Employees Stock Option Scheme, 2002. This allotment, approved by the Nomination, Governance and Compensation Committee, took place on November 21, 2023. The shares rank pari passu with existing shares and reflect ongoing employee participation in the company's equity structure. The announcement complies with SEBI regulations regarding share-based employee benefits.

Market Sentiment Analysis

POSITIVE FACTORS

  • Allotment of equity shares reflects company commitment to employee engagement.
  • Equity shares issued under a longstanding employee stock option scheme.
  • The total issued share capital shows growth potential.
  • Compliance with SEBI regulations demonstrates corporate governance.

Full Press Release Details

National Stock Exchange of India Ltd. (Stock Code: DRREDDY-EQ)
BSE Ltd. (Stock Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd. (Stock Code: DRREDDY)
Ref: Disclosure under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
Sub: Allotment of Equity Shares on exercise of Stock Options under ESOPs
This is to inform you that the Nomination, Governance
and Compensation Committee of the Board of Directors of the Company has approved the allotment of 3,362 equity shares of Rs.5/- each pursuant
to Dr. Reddy's Employees Stock Option Scheme, 2002 of the Company, fully paid up, on November 21, 2023, to employee(s) pursuant to exercise
Further, please find enclosed the details as required
under Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
This is for your information and records.
For Dr. Reddy's Laboratories Limited
Company Secretary, Compliance Officer & Head-CSR
Details under Regulation 10(c) of the SEBI (Share
Based Employee Benefits and Sweat Equity) Regulations, 2021
1 Company name and address of Registered Office: Dr. Reddy's Laboratories Limited 8-2-337, Road No.3, Banjara Hills, Hyderabad - 500034
2 Name of the Stock Exchanges on which the company's shares are listed: BSE Limited National Stock Exchange of India Limited New York Stock Exchange Inc. (ADRs) NSE IFSC Limited (ADRs)
3 Filing date of the statement referred in Regulation 10(b) of the SEBI (Share Based Employee Benefits) Regulations, 2021 with Stock Exchange: The Schemes were institutionalised under the erstwhile the SEBI (Employee Stock Option Scheme and Employee Stock Purchase Scheme) Guidelines, 1999 and appropriate details under Schedule V were filed. The Schemes comply with provisions of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
4 Filing Number, if any: NA
5 Title of the Scheme pursuant to which shares are issued, if any: Dr. Reddy's Employees Stock Option Scheme, 2002
6 Kind of security to be listed: Equity Shares
7 Par value of the shares: Rs. 5/-
8 Date of issue of shares: November 21, 2023 (Date of allotment on exercise)
9 Number of shares issued: 3,362 equity shares
10 Share Certificate No., if applicable: NA
11 Distinctive number of the share, if applicable: 213199659 to 213203020
12 ISIN Number of the shares if issued in Demat: INE089A01023
13 Exercise price per share: 12,090 equity shares exercised at Rs. 5/- per share
14 Premium per share: Nil
15 Total Issued shares after this issue: 16,68,00,416 (*)
16 Total Issued share capital after this issue: Rs. 83,40,02,080 /-
17 Details of any lock-in on the shares: NA
18 Date of expiry of lock-in: NA
19 Whether shares identical in all respects to existing shares if not, when will they become identical? Yes, the shares rank pari passu with the existing shares
20 Details of listing fees, if payable: NA

Frequently Asked Questions

What is the stock code for Dr. Reddy's Laboratories on NSE?

The stock code is DRREDDY-EQ.

How many equity shares were allotted on November 21, 2023?

A total of 3,362 equity shares were allotted.

What is the par value of Dr. Reddy's equity shares?

The par value of the shares is Rs. 5/-.

What scheme issued the equity shares?

The shares were issued under the Employees Stock Option Scheme, 2002.

Do the newly issued shares rank equally with existing shares?

Yes, the new shares rank pari passu with existing shares.

Last updated: Nov 21, 2023